Pemetrexed safety and dosing strategy

被引：36

作者：

Niyikiza, C

Hanauske, AR

Rusthoven, JJ

Calvert, AH

Allen, R

Paoletti, P

Bunn, PA

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

[2] Gen Hosp St Georg, Hamburg, Germany

[3] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[4] Univ Colorado, Ctr Canc, Denver, CO 80262 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37465

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：24 / 29

页数：6

共 17 条

[1]

BUNN P, 2001, P AN M AM SOC CLIN, V20, pA76

[2]

ETTINGER DS, 2002, P AN M AM SOC CLIN, V21, pA311

[3]

GRINDEY G B, 1991, Proceedings of the American Association for Cancer Research Annual Meeting, V32, P324

[4]

Pemetrexed disodium: A novel Antifolate clinically active against multiple solid tumors [J].

Hanauske, AR ;

Chen, V ;

Paoletti, P ;

Niyikiza, C .

ONCOLOGIST, 2001, 6 (04) :363-373

[5]

Folate-based thymidylate synthase inhibitors as anticancer drugs [J].

Jackman, AL ;

Calvert, AH .

ANNALS OF ONCOLOGY, 1995, 6 (09) :871-881

[6]

KINDLER HL, 2002, P AN M AM SOC CLIN, V21, pA125

[7]

Folate-homocysteine interrelations: Potential new markers of folate status [J].

Lucock, MD ;

Daskalakis, I ;

Schorah, CJ ;

Lumb, CH ;

Oliver, M ;

Devitt, H ;

Wild, J ;

Dowell, AC ;

Levene, MI .

MOLECULAR GENETICS AND METABOLISM, 1999, 67 (01) :23-35

[8]

Niyikiza C, 2002, MOL CANCER THER, V1, P545

[9]

ROSENBERG LE, 1989, METABOLIC BASIS INHE, P821

[10]

Thymidylate synthase inhibitors in cancer therapy: Direct and indirect inhibitors [J].

Rustum, YM ;

Harstrick, A ;

Cao, SS ;

Vanhoefer, U ;

Yin, MB ;

Wilke, H ;

Seeber, S .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :389-400

← 1 2 →